- July 19, 2024
- Category: What's New
Designed for both offline and online adaptive workflows and compatible with all conventional linacs and energies, as well as with the Elekta Unity MR-Linac, ThinkQA Secondary Dose Check provides physicists with reliable, automated, and 3D independent calculation-based dose verification. This guarantees adherence to QA regulatory standards for the latest radiotherapy equipment and practices, in particular for Adaptive Radiation Therapy (ART).
With seamless integration and streamlined workflow, ThinkQA Secondary Dose Check enables routine TPS plan verification via an ergonomic web-based interface. Users can effortlessly access an overall QA outcome dashboard, visualize relevant dose comparison metrics, and receive automatically generated reports for each plan and patient.
DOSIsoft is pleased to announce the new features incorporated in the enhanced version of ThinkQA Secondary Dose Check 2.0.2:
Expert module – in-depth QA insights based on 3D patient anatomical visualization
Explore how ThinkQA SDC enables users to better evaluate discrepancies and the acceptability of secondary dose verification: display of Patient density matrix for dose calculation and overlay with the gamma index map.
Electron Return Effect Impact Analysis
Discover how ThinkQA SDC enables users to reassess the results of secondary dose checks for MR-Linac plans by considering Electron Return Effects in the Expert module.
- Mitigating the ERE effects with display of γ-index indicators on Filtered ROIs volumes (where potential Electron Return Effects areas have been removed)
- Comparing γ-index histograms between Raw ROI and Filtered ROI, on four automatic volumes, PTV as well as additional ROI
Clinically-proven and validated CCC algorithms
Experience how ThinkQA SDC is fast enough to be compatible with online VMAT adaptive RT: average dose calculation time is less than 2 minutes, ensuring treatment efficiency.
Meet with our team & attend a live demo
DOSIsoft is excited to see an increasing number of clinics adopting ThinkQA Secondary Dose Check, providing both patient safety and treatment delivery quality for adaptive radiation therapy.
- DOSIsoft booth #19 during ECMP Conference – September 11-14, 2024 Munich, Germany
- Elekta booth #2227 during ASTRO Annual Meeting – September 29 – October 2, 2024, Washington, DC, USA
About ThinkQA Secondary Dose Check
ThinkQA (Edition 2) is CE marked as a class I medical device in Europe, under the new European Medical Device Regulation (EU) 2017/745. ThinkQA (Edition 2) is FDA 510(k) cleared as class II Medical Charged-Particle Radiation Therapy System. ThinkQA Secondary Dose Check is seamlessly integrated into Elekta ONE®, and is exclusively distributed by Elekta. www.elekta.com.
To order the product, please contact your Elekta sales representatives.
About DOSIsoft
Founded in 2002, DOSIsoft designs, develops & delivers patient-specific imaging & dosimetry software solutions in Radiation Oncology & Nuclear Medicine to improve cancer patient safety & treatment quality. More than 20 years of innovation and R&D investments have led to world leading software used in over 600 hospital centres in 60 countries. Spin-off between Gustave Roussy and Institut Curie, DOSIsoft constantly innovates in partnership with the major cancer institutes and research centres in the world. It is now recognized as a key player in the dosimetry market. www.dosisoft.com